Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

被引:14
|
作者
Lukka, H. [1 ]
Stephanie, P. [2 ]
Bruner, D. [3 ]
Bahary, J. P. [4 ]
Lawton, C. A. F. [5 ]
Efstathiou, J. A. [6 ]
Kudchadker, R. [7 ]
Ponsky, L. [8 ]
Seaward, S. A. [9 ]
Dayes, I. S. [10 ]
Gopaul, D. D. [11 ]
Michalski, J. M. [12 ]
Delouya, G. [13 ]
Kaplan, I. D. [14 ]
Horwitz, E. M. [15 ]
Roach, M., III [16 ]
Pinover, W. H. [17 ]
Beyer, D. C. [18 ]
Sandler, H. M. [19 ]
Kachnic, L. A. [20 ]
机构
[1] Juravinski Canc Ctr Hamilton Hlth Sci, Hamilton, ON, Canada
[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Hop Notre Dame CHUM, Montreal, PQ, Canada
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[9] Kaiser Permanente No Calif, Santa Clara, CA USA
[10] McMaster Univ, Hamilton, ON, Canada
[11] Grand River Reg Canc Ctr, Kitchener, ON, Canada
[12] Washington Univ, Sch Med, St Louis, MO USA
[13] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[14] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[15] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[16] Univ Calif San Francisco, San Francisco, CA 94143 USA
[17] Abington Mem Hosp, Abington, PA 19001 USA
[18] Fdn Canc Res & Educ, Phoenix, AZ USA
[19] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[20] Boston Med Ctr, Boston, MA USA
关键词
D O I
10.1016/j.ijrobp.2015.10.046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA 3
引用
收藏
页码:2 / 2
页数:1
相关论文
共 50 条
  • [21] Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer
    Garden, Adam S.
    Harris, Jonathan
    Eisbruch, Avraham
    Chao, K. S. Clifford
    Morrison, William H.
    Harari, Paul M.
    Swanson, Todd Allen
    Jones, Christopher U.
    Yom, Sue S.
    Spencer, Sharon A.
    Scrimger, Rufus
    Shenouda, George
    Shukla, Monica
    Lau, Harold Y.
    Mierzwa, Michelle
    Torres-Saavedra, Pedro
    Le, Quynh Thu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : 333 - 340
  • [22] Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study
    Tetar, Shyama U.
    Bruynzeel, Anna M. E.
    Oei, Swie S.
    Senan, Suresh
    Fraikin, Tamara
    Slotman, Berend J.
    van Moorselaar, R. Jeroen A.
    Lagerwaard, Frank J.
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (04): : 628 - 634
  • [23] Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Hartford, Chris
    Dain, Bradley
    Sherman, Steven
    Zhang, Yi
    Pavani, Rodrigo
    Aurand, Lisa
    Rofail, Diana
    Kelly, Richard
    BLOOD, 2022, 140 : 10849 - 10850
  • [24] EFFECT OF FILGOTINIB ON PATIENT-REPORTED OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY
    Coates, Laura C.
    Mease, Philip J.
    Gladman, Dafna D.
    van den Bosch, Filip
    Tasset, Chantal
    Meuleners, Luc
    Besuyen, Robin
    Gao, Jingjing
    Trivedi, Mona
    Hendrikx, Thijs
    Helliwell, Philip
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1269 - 1270
  • [25] Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.
    Ganz, Patricia A.
    Cecchini, Reena S.
    White, Julia R.
    Vicini, Frank
    Julian, Thomas B.
    Arthur, Douglas W.
    Rabinovitch, Rachel
    Kuske, Robert R.
    Parda, David S.
    Scheier, Michael
    Winter, Kathryn A.
    Paik, Soonmyung
    Kuerer, Henry Mark
    Vallow, Laura
    Pierce, Lori J.
    Mamounas, Eleftherios P.
    Costantino, Joseph P.
    McCormick, Beryl
    Curran, Walter John, Jr.
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
    Spratt, Daniel E.
    Liu, Vinnie Y. T.
    Michalski, Jeff
    Davicioni, Elai
    Berlin, Alejandro
    Simko, Jeffry P.
    Efstathiou, Jason A.
    Tran, Phuoc T.
    Sandler, Howard M.
    Hall, William A.
    Thompson, Darby J. S.
    Parliament, Matthew B.
    Dayes, Ian S.
    Correa, Rohann Jonathan Mark
    Robertson, John M.
    Gore, Elizabeth M.
    Doncals, Desiree E.
    Vigneault, Eric
    Souhami, Luis
    Karrison, Theodore G.
    Feng, Felix Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : 370 - 377
  • [27] Patient-reported outcomes after surgery or radiotherapy for localised prostate cancer: a retrospective study
    Ng, C. F.
    Kong, K. Y.
    Li, C. Y.
    Li, Jennifer K. T.
    Li, N. Y.
    Ng, Brian P. K.
    Leung, Steven C. H.
    Hong, Cindy Y. L.
    Yee, C. H.
    Teoh, Jeremy Y. C.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (02) : 95 - 101
  • [28] NRG Oncology RTOG 0415: A randomized phase III non-inferiority study comparing two fractionation schedules in patients with low-risk prostate cancer
    Lee, W. Robert
    Dignam, James J.
    Amin, Mahul
    Bruner, Deborah
    Low, Daniel
    Swanson, Gregory P.
    Shah, Amit
    D'Souza, David
    Michalski, Jeff M.
    Dayes, Ian
    Seaward, Samantha A.
    Hall, William Adrian
    Nguyen, Paul L.
    Pisansky, Thomas Michael
    Faria, Sergio
    Chen, Yuhchyau
    Koontz, Bridget F.
    Paulus, Rebecca
    Sandler, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [29] A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer
    Helou, Joelle
    Morton, Gerard
    Kiss, Alex
    Mittmann, Nicole
    Ravi, Ananth
    Chung, Hans
    Davidson, Melanie
    Cheung, Patrick
    Bezjak, Andrea
    Loblaw, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2022, 171 : 164 - 172
  • [30] Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial
    Movsas, B.
    Rodgers, J.
    Elshaikh, M. A.
    Martinez, A. A.
    Morton, G.
    Krauss, D. J.
    Yan, D.
    Citrin, D. E.
    Hershatter, B.
    Michalski, J. M.
    Ellis, R. J., III
    Kavadi, V. S.
    Gore, E. M.
    Gustafson, G. S.
    Schulz, C. A.
    Velker, V.
    Olson, A. C.
    Karrison, T. G.
    Sandler, H. M.
    Bruner, D. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S3 - S3